I agree on the financial and promotional incompetence of this lot. We could not have any worse management. Who needs enemies (shorters) with friends like these? The OTC argument is BS as far as I'm concerned. Any share can do very well on the OTC market provided the company is in capable hands. These guys have time and time again disappointed the market by delays and other FU's that we're all aware of.
Against better judgement added today. I refuse to accept things can not turn out for the better. Must be crazy.
Share price is irrelevant to management right now. They have bigger issues at hand that once worked out, the sp will take care of itself. While in these trials they have to be very careful about what is said and published publicly. Last thing we need is an issue with the FDA. They already like the prospects of this drug so management is doing what is necessary to stay on their good side. They have attorneys help draft these pr’s to keep their nose clean. I feel they learned lesson from over promoting “golden quarter” last year and are keeping their heads down and chugging along.
News 
Market Data 
Discover 
